Back to results
US 2022/0016217 A1Published application
Combination of an insulin and a glp-1-agonist
AssigneeSanofi-Aventis Deutschland GmbH
InventorsUlrich Werner, Barbel Rotthauser
Life of this patent
Estimating the term…
Abstract
The invention relates to a drug comprising at least one insulin and at least one GLP-1 receptor agonist.
Claims14
A pharmaceutical composition comprising at least one insulin and at least one GLP-1 agonist, and pharmaceutically acceptable salts thereof, wherein said pharmaceutical composition comprises the insulin and the GLP-1 agonist each in a predetermined amount, and is administered in a dose adapted to the individual requirement of a patient.
Dependencies are inferred from the claim text.